Education
About Us
Working with TipRanks
Follow Us
James Bierman Insider Profile
4 Followers
James Bierman, President & CEO at Accendra Health, holds 212.77K shares in MiMedx Group (Ticker: MDXG), holds 35.27K shares in Tenet Healthcare (Ticker: THC), holds 40.10K shares in Novan (Ticker: NOVN).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-64.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Bierman holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Bierman
James Bierman's Trading History
Accendra Health
Mar 10, 2015
President & CEO
Uninformative Sell
87.92K
$225.73K
Tenet Healthcare
May 30, 2025
Director
Uninformative Sell
784.21K
$8.44M
MiMedx Group
Jun 23, 2025
Director
Uninformative Buy
185.10K
$1.04M
Novan
Jun 08, 2023
Director
Uninformative Buy
33.00K
―
Team Health Holdings
Feb 08, 2017
―
Uninformative Sell
843.20K
$953.96K
List of latest transactions for each holding click on a transaction to see James Bierman's performance on stock
You May Also Like
James Bierman insider profile FAQ
What is the percentage of profitable transactions made by James Bierman?
The percentage of profitable transactions made by James Bierman is 0%.
What is the average return per transaction made by James Bierman?
The average return per transaction made by James Bierman is -64.70%.
What stocks does James Bierman hold?
James Bierman holds: ACH, THC, MDXG, NOVN, ~TMH stocks.
What was James Bierman’s latest transaction?
James Bierman latest transaction was an Uninformative Buy of $185.10K.
What was James Bierman's most profitable transaction?
James Bierman’s most profitable transaction was an Informative Buy of NOVN stock on April 11, 2022. The return on the trade was -59.30%.
What is James Bierman's role in Accendra Health?
James Bierman's role in Accendra Health is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.